Formulate a three-year strategic marketing plan to improve KromaTiD visibility and engagement with key players in the US and European Cell and Gene Therapy sector. Secondly, identify additional market segments where opportunities exist for KromaTiD products and services.

Develop a strategy to direct members to urgent care/clinical decision units (CDU) and reduce over utilization of emergency departments.

Develop a U.S. market entry plan for KSI